Company / Tangible Book Value per Share
Jade Biosciences, Inc. Tangible Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.67
FY2024
5-year range
-$55.09 / $14.02
FY2020-FY2024
Trend
-35.7%
vs FY2023
Sector context
#134 of 207
Health Care
What the data says
At $2.67, Jade Biosciences, Inc.'s tangible book value per share ranks #134 of 207 in the Health Care sector. Tangible Book Value per Share has declined for 3 consecutive years, from $14.02 in FY2021 to $2.67 in FY2024.
Based on SEC 10-K filings.
2.67 in FY2024 with a 3-year CAGR of -42.4%.
Declined from $5.18 to $2.67 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -42.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#134 of 207 in Health CareTop 65% of 207This company $2.67 Sector average $111.62
▼
-97.6% below sector average
Key checks
Key Insights
- Jade Biosciences, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2024, tangible book value per share decreased 35.7% year-over-year.
- Ranks #134 out of 207 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.67 | -35.7% |
| FY2023 | $4.16 | -19.7% |
| FY2022 | $5.18 | -63.1% |
| FY2021 | $14.02 | +125.5% |
| FY2020 | -$55.09 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026